Welcome to ATMP Sweden

ATMP Sweden is the national network of Sweden’s activities within medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. Our goal is to promote the collaboration and communication needed for accelerated, effective ATMP based patient solutions.

Learn about membership

CGT Sweden

Establishing a sustainable national coordination function for Advanced Therapies that strengthens regional centres, supports clinical research, ensures equitable patient access to treatment, and facilitates translation into development and manufacturing.

Learn more

What are ATMPs?

Advanced Therapy Medicinal Products (ATMPs) are a new generation of medicines based on genes, cells, or engineered tissues that can repair, replace, or modify biological functions in the body. These innovative therapies are transforming how diseases can be treated, and sometimes even cured – creating new possibilities for patients with conditions that previously had limited treatment options.

Learn more

National ATMP Center Network

NACNET brings together the ATMP centers at Sweden’s university hospitals, each a regional knowledge center and contact point for advanced therapies, working as one national network to accelerate translational research, clinical trials and the implementation of ATMPs in Swedish healthcare.

Meet the centers
NHTA University of Oslo aims for first Norwegian opportunity cost estimate in 2027 8 September 2026 DBMD Idag den 7 september är det World Duchenne Awareness Day 7 September 2026 NHTA Medicinrådet issues two green lights and two red lights 4 September 2026 DBMD En gemenskap för syskon och anhöriga 2 September 2026 Testa Center Testa Center Access Grant 2026-2027 18 August 2026 OptiCell Solutions Sweden has a strong opportunity to strengthen its international position in advanced therapy medicinal products (ATMPs) 6 August 2026 News Archive | VERIGRAFT – Personalized Grafts VERIGRAFT Q2 2026 – Advancing Clinical Execution 3 July 2026 News Archive | VERIGRAFT – Personalized Grafts VERIGRAFT and BBG Advanced Therapies collaborate on P-TEV U.S. readiness 24 June 2026 Testa Center Testa Challenge 2026 Companies Announced 24 June 2026 Alla nyheter Swetrial öppnar utlysningar för att stärka Sveriges kapacitet för kliniska prövningar 1 June 2026 ATMP Flemingsberg Neighbors in collaboration: New partnerships emerge at Novum Labs 29 May 2026 Alla nyheter Ny pusselbit stärker Sveriges position för kliniska prövningar 23 April 2026 QAlliance Course: Advanced GCP in action 8 April 2026 QAlliance Stories from a GCP inspector – part 6 31 March 2026 Vävnadsrådet Viktig information om humanmaterialförordningen 24 March 2026 Magle Biopharma Proud Collaboration Highlight from Path2 Patient Conference 2026 24 March 2026 Magle Biopharma Magle Biopharma had the pleasure of hosting the concluding scientific seminar of the HyperTargIPS-NK project. 11 March 2026 Clinical Trial Consultants We are delighted to welcome two new board members, Pernilla Sandwall and Marie Gårdmark, to Clinical Trial Consultants 6 March 2026 Vävnadsrådet Bröstmjölk och tarmflora: Informationsmöte 11 February 2026 OptiCell Solutions OptiCell Solutions AB delivers first cell material to Karolinska Institutet under research collaboration 5 February 2026 Swelife Nationell samordningsfunktion kring ATMP 4 February 2026 ATMP Flemingsberg 50 years of life-changing therapies 16 December 2025 Swelife EHDS börjar med indata 9 October 2025 Clinical Trial Consultants Meet our people pt. 9 – Dr. Ulrika Risedal, MD, Resident in Clinical Pharmacology 26 September 2025 ASCRO Vägledning 2.0 – viktiga framgångsfaktorer när kliniska läkemdelsprövningar initieras och genomförs i Sverige 10 September 2025 NMS New Modalities Nordic Investor Forum in September attracts top investors, academia and industry leaders – ”Interest is high – and rightly so” 12 June 2025 HoloMonitor HoloMonitor publication highlight 2024 28 April 2025 ASCRO Vägledning för kliniska prövningar nu tillgänglig på engelska 3 February 2025 IndiCell Alice Hägg, klarade halvtidsrecension med beröm 25 September 2024 IndiCell Jana Bonsberger, utför sin halvrecension på ett exceptionellt sätt 20 September 2024 HoloMonitor HoloMonitor User Spotlight: Besa Xhabija 3 June 2024 NHTA University of Oslo aims for first Norwegian opportunity cost estimate in 2027 8 September 2026 DBMD Idag den 7 september är det World Duchenne Awareness Day 7 September 2026 NHTA Medicinrådet issues two green lights and two red lights 4 September 2026 DBMD En gemenskap för syskon och anhöriga 2 September 2026 Testa Center Testa Center Access Grant 2026-2027 18 August 2026 OptiCell Solutions Sweden has a strong opportunity to strengthen its international position in advanced therapy medicinal products (ATMPs) 6 August 2026 News Archive | VERIGRAFT – Personalized Grafts VERIGRAFT Q2 2026 – Advancing Clinical Execution 3 July 2026 News Archive | VERIGRAFT – Personalized Grafts VERIGRAFT and BBG Advanced Therapies collaborate on P-TEV U.S. readiness 24 June 2026 Testa Center Testa Challenge 2026 Companies Announced 24 June 2026 Alla nyheter Swetrial öppnar utlysningar för att stärka Sveriges kapacitet för kliniska prövningar 1 June 2026 ATMP Flemingsberg Neighbors in collaboration: New partnerships emerge at Novum Labs 29 May 2026 Alla nyheter Ny pusselbit stärker Sveriges position för kliniska prövningar 23 April 2026 QAlliance Course: Advanced GCP in action 8 April 2026 QAlliance Stories from a GCP inspector – part 6 31 March 2026 Vävnadsrådet Viktig information om humanmaterialförordningen 24 March 2026 Magle Biopharma Proud Collaboration Highlight from Path2 Patient Conference 2026 24 March 2026 Magle Biopharma Magle Biopharma had the pleasure of hosting the concluding scientific seminar of the HyperTargIPS-NK project. 11 March 2026 Clinical Trial Consultants We are delighted to welcome two new board members, Pernilla Sandwall and Marie Gårdmark, to Clinical Trial Consultants 6 March 2026 Vävnadsrådet Bröstmjölk och tarmflora: Informationsmöte 11 February 2026 OptiCell Solutions OptiCell Solutions AB delivers first cell material to Karolinska Institutet under research collaboration 5 February 2026 Swelife Nationell samordningsfunktion kring ATMP 4 February 2026 ATMP Flemingsberg 50 years of life-changing therapies 16 December 2025 Swelife EHDS börjar med indata 9 October 2025 Clinical Trial Consultants Meet our people pt. 9 – Dr. Ulrika Risedal, MD, Resident in Clinical Pharmacology 26 September 2025 ASCRO Vägledning 2.0 – viktiga framgångsfaktorer när kliniska läkemdelsprövningar initieras och genomförs i Sverige 10 September 2025 NMS New Modalities Nordic Investor Forum in September attracts top investors, academia and industry leaders – ”Interest is high – and rightly so” 12 June 2025 HoloMonitor HoloMonitor publication highlight 2024 28 April 2025 ASCRO Vägledning för kliniska prövningar nu tillgänglig på engelska 3 February 2025 IndiCell Alice Hägg, klarade halvtidsrecension med beröm 25 September 2024 IndiCell Jana Bonsberger, utför sin halvrecension på ett exceptionellt sätt 20 September 2024 HoloMonitor HoloMonitor User Spotlight: Besa Xhabija 3 June 2024
ATMP Sweden 2026

ATMP Sweden 2026

The premiere national meetup for the Swedish ATMP ecosystem is coming to Campus Flemingsberg in Stockholm, December 2026.

Read more
Poster Session

Poster Session

ATMP Sweden 2026 will host a poster / abstract zone. Submissions go through a review process – applicants who have their submission chosen will be notified via email. Deadline 16th October 2026.

Submission Form
ATMP Sweden Webinars

ATMP Sweden Webinars

Join to learn from experts, patient advocates, and rising stars within ATMPs:

Read more

Events

Rigshospitalet, Copenhagen University Hospital Nordic Society of Human Genetics and Precision Medicine (NSHG-PM), NVIDIA, Rigshospitalet, Copenhagen University Hospital

A three-day federated learning hackathon for biomedical applications, hosted by NSHG-PM, NVIDIA and Rigshospitalet in Copenhagen. Free to attend, by application only, and held alongside the Nordic Conference on Future Health 2026.

23 September 2026 Seminar

Don’t stop believin’ (in cell therapy)

Novum, Blickagången 6, Huddinge Miltenyi Biotec, Flemingsberg Science Foundation Miltenyi Biotec Norden AB

Miltenyi Biotec Nordics and Flemingsberg Science Foundation gather scientists and clinicians in Flemingsberg for a half-day seminar on where cell therapy stands and which engineered advances are driving it forward.

Miltenyi Biotec and Cellerator close their 2026 cell therapy series in Copenhagen with an afternoon on translation and production, covering CAR-T implementation, stem cell research reaching the clinic, and a Q&A roundtable.

Bistro Merge, 223 63 Lund, Sverige Region Skåne, Smile Venture Hub, Medicon Village, Lund Innovation Lund Innovation

Understanding early decisions in ATMP research and development

News

Testa Center access grant part-funds bioprocess scale-up weeks

Bioprocess development at Testa Center in Uppsala is now part-funded again: up to five weeks of access per project, with 70 percent of the access fee covered for academic projects and 50 percent for companies. Weeks are allocated first come, first served and must be used by 30 April 2027.

Sahlgrenska to establish pre-GMP laboratory for ATMP developers
Sahlgrenska Universitetssjukhuset Sahlgrenska Universitetssjukhuset Original source

A pre-GMP laboratory in Western Sweden will let ATMP developers prove out their manufacturing processes before committing to a GMP facility. It is one of two resources in Precisionsplattformen, backed by SEK 25 million in EU regional development and Västra Götalandsregionen funding.

IVA ATMP report: what Sweden must fix to stay competitive
Royal Swedish Academy of Engineering Sciences (IVA) Original source

The Royal Swedish Academy of Engineering Sciences has set out what Sweden needs to change to hold its position in advanced therapies. The IVA ATMP report asks for three national super-ecosystems, a transferable fast-track voucher at EU level and clearer national guidance on the hospital exemption.

2026-04-23 Jobs, Careers & Opportunities

Join the ESGCT ECR Board – Apply by 15 May 2026

Join the ESGCT ECR Board – Apply by 15 May 2026

The European Society of Gene and Cell Therapy is looking for its next ECR Board Member. Are you a PhD student or post-doc in gene and cell therapy? Applications close 15 May 2026.

Doctoral Course: From Research to ATMP Treatment
Flemingsberg Science Foundation natasha.bank@flemingsbergscience.se

Doctoral Course: From Research to ATMP Treatment

BioLamina secures €20M to scale cell therapy tech

EIB backs Swedish biotech scale-up BioLamina with €20 million to enable stem cell technologies targeting diseases such as type 1 diabetes, Parkinson’s disease, and heart failure

Commercial Aspects of ATMPs
Commercial aspects of ATMPs

Learn more about the Health Technology Assessment related issues of your ATMP development.

ATMP Process Map
ATMP Process Map

Support in navigating ATMP development needs prompting the right competence, need, and time.

Job Board
Job Board

Find or advertise ATMP relevant job opportunities.

Newsletter
Newsletter

The ATMP Sweden newsletter provides updates on Swedish ATMP- and association developments.